News

RCSI celebrates over 400 graduates, including first Advanced Therapeutic Technologies cohort

  • General news
  • Alumni
Four people in formal attire standing outdoors beside a large bronze winged sculpture, with a modern glass-fronted RCSI building and landscaped planting in the background.

RCSI University of Medicine and Health Sciences continued its Winter Conferring celebrations on 19 November 2026, recognising the achievements of more than 400 graduates across three ceremonies held at RCSI.

The ceremonies marked a significant milestone for RCSI, with the first cohort of students graduating from the BSc in Advanced Therapeutic Technologies. The innovative, skills-focused programme equips graduates with knowledge and expertise in emerging technologies and scientific advances, preparing them for careers in the rapidly evolving life sciences sector.

Graduates were presented by Professor Cathal Kelly, Vice Chancellor of RCSI, and conferred by Professor Michael Kerin, President of RCSI.

The morning ceremony celebrated the achievements of 143 graduates across a range of undergraduate and postgraduate programmes, including the BSc in Physiotherapy, MSc programmes in Neurology and Gerontology, and professional and postgraduate qualifications in Positive Health Sciences.

Celebrations continued with a further 130 graduates receiving postgraduate qualifications in Health Professions Education, alongside Master of Science (MSc), Master of Surgery (MCh), Doctor of Medicine (MD) and Doctor of Philosophy (PhD) degrees.

A highlight of the postgraduate conferring ceremony was the awarding of an Honorary Doctorate to Professor Yasmine Belkaid, President of the Institut Pasteur and Head of the Metaorganism Laboratory at the Institut Pasteur in Paris, in recognition of her pioneering contributions to immunology. Professor Belkaid's research has advanced understanding of the complex interactions between the microbiota, nutrition, infection and the immune system. Her work has transformed understanding of how the immune system responds to environmental exposures, providing important insights into the mechanisms that influence human health and disease.

The final ceremony of the day celebrated 168 graduates from RCSI's School of Pharmacy and Biomolecular Sciences. Graduates received qualifications including the BSc in Pharmacy, Master of Pharmacy (MPharm) and MSc in Technologies and Analytics in Precision Medicine.

The ceremony recognised the first graduates of the BSc in Advanced Therapeutic Technologies, marking an important milestone for the programme and reflecting RCSI's commitment to preparing graduates with the skills and expertise needed to advance innovation in healthcare and the life sciences.

Congratulating the graduates on their achievements, Professor Cathal Kelly, Vice Chancellor of RCSI, said: “Your achievements, as recognised today, reflect years of hard work and a shared ambition to make a meaningful contribution to healthcare and the lives of patients. I extend my warmest congratulations to each of you as you take the next steps in your careers in health sciences.